Blue Owl Capital Holdings LP - Significant Ownership

Signature - Title
Karen Hager - Chief Compliance Officer
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Blue Owl Capital Holdings LP.

Significant Ownership of Blue Owl Capital Holdings LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FS Credit Opportunities Corp. Term Preferred Shares 16.67% 50K Blue Owl Capital Holdings LP Dec 31, 2024
CNTX Context Therapeutics Inc. Common Stock, par value $0.001 per share 8.48% $5.02M 6.36M Blue Owl Capital Holdings LP Dec 31, 2024
LFTPRA Lument Finance Trust, Inc. 7.875% Series A Cumulative Redeemable Preferred Stock, par value $0.01 per share 8.33% $4.57M 200K Blue Owl Capital Holdings LP Dec 31, 2024
ABRPRE ARBOR REALTY TRUST INC 6.25% Series E Cumulative Redeemable Preferred Stock, par value $0.01 per share 6.26% $6.3M 360K Blue Owl Capital Holdings LP Dec 31, 2024
MRKR Marker Therapeutics, Inc. Common Stock, $0.001 par value 5.18% $665K 554K Blue Owl Capital Holdings LP Dec 31, 2024
SGMT Sagimet Biosciences Inc. Series A common stock, $0.0001 par value per share 4.32% $4.32M 1.32M Blue Owl Capital Holdings LP Dec 31, 2024
TRML Tourmaline Bio, Inc. Common Stock, $0.0001 par value per share 4.2% $16.4M 1.08M Blue Owl Capital Holdings LP Dec 31, 2024
AEON AEON Biopharma, Inc. Class A common stock, par value $0.001 per share 3.81% $213K 3.05M Blue Owl Capital Holdings LP Dec 31, 2024
GAQ Generation Asia I Acquisition Ltd Class A ordinary shares, par value $0.0001 0% $0 0 Blue Owl Capital Holdings LP Dec 31, 2024

Schedules 13D/G Reported by Blue Owl Capital Holdings LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.